'Outcomes play a more important role than ever before, yet there is still a gap between hospital care delivery and home health management. For an undisclosed sum, PatientSafe, a San Diego-based developer of mobile care coordination and connected workflow solutions, is buying Vree's care coordination technology to both drive positive behavioral changes and enhance patients' experience in the care system. Patient engagement has become one of the more popular catchphrases in healthcare these days, thanks in part to its inclusion in meaningful use incentives and Medicare reimbursements tied to patient satisfaction surveys. Healthcare providers are becoming especially mindful of the issues in a patient's transition from the hospital to the extended care facility or the home, where a lapse could negatively affect clinical outcomes. "In this era of healthcare reform and value-based care, outcomes play a more important role than ever before; yet there is still a gap between hospital care delivery and home health management," Joe Condurso, PatientSafe's president and CEO, said in a press release. That's the sweetspot for PatientSafe. Vree's EngageAdvantage platform pulls in provider data from different sources and makes it available to patients and their caregivers for use in a wellness and care management plan. The Annandale, N.J.-based Vree is a wholly owned subsidiary of pharma giant Merck, whose Merck Global Health Innovation Fund is an investor in PatientSafe. See also:

PatientSafe scoops up Merck unit

November 24, 2014 --
Washington, DC (PRWEB) November 24, 2014
The Population Health Alliance, (PHA) a leading non-profit organization dedicated to advancing the principles of population health, announced today that it has welcomed six new member organizations to its growing association. New members include Vree Health, Omada Health, MassMedia, Dynamed Solutions, Healogics, and the Department of Health & Hospitals, State of Louisiana. Theres a rapidly growing awareness of the critical need to address overall population health  and thats driving both adoption and delivery innovation, said Fred Goldstein, executive director of the Population Health Alliance. Were thrilled to welcome these organizations, representing both sides of the equation, and look forward to their contributions to our joint efforts. PHA members work in a collaborative environment, and charter the agenda for the population health industry as a whole, through advocacy and research efforts. This results in a community that shares information, data and outcomes among employers, payers, innovative technology startups, long-term providers of population health management solutions, and others. The PHA Forum 2014 in Scottsdale, Arizona, Dec. 10-12, is organized around the theme of Collaborate + Communicate = Engage and will give new and current PHA members an opportunity to connect face to face on population health trends. New PHA members include:
Vree Health is dedicated to developing best-in-class, technology-enabled services that meet the needs of health care organization and consumers for highlight effective, cost-efficient care. Learn more at http://www.vreehealth.com/
Omada Health is leading the field of digital therapeutics by creating innovative, scalable, and cost-effective online behavior change programs that address the growing epidemic of chronic disease. Their flagship product Prevent is based on the landmark Diabetes Prevention Program,  and has been shown in a clinical trial to help people lose weight and positively impact risk factors that contribute to Type 2 diabetes. Learn more at https://omadahealth.com/
MassMedia is a full-service communications firm that offers effective advertising, brand development, online marketing, public relations and media buying services  all grounded in insightful strategy. Founded in 1997, their diverse team is comprised of seasoned public relations professionals, former news reporters, graphic designers and social media specialists dedicated to an integrated approach to communication. Learn more at http://www.massmediacc.com/
Dynamed Solutions was founded in 2007, by leveraging the successful history and infrastructure of Dynanet Corporation and focusing on the growing health care information technology market. Dynamed's founders have deep experience in all aspects of health care, information technology, customer service, and innovative solutions. Learn more at http://www.dynamedsolutions.com
Healogics is the nations leading provider of advanced wound care services, developing successful wound healing treatment and prevention techniques. Along with its affiliated companies, it manages nearly 600 outpatient Wound Care Centers in the United States, Puerto Rico and United Kingdom, and is disease-specific certified in wound care by The Joint Commission. Learn more at http://www.healogics.com
The Department of Health & Hospitals, State of Louisiana has a mission to protect and promote health and to ensure access to medical, preventive and rehabilitative services for all citizens of the State of Louisiana. It is dedicated to fulfilling its mission through direct provision of quality services, the development and stimulation of services of others, and the use of available resources in the most effective manner. Learn more at http://www.dhh.state.la.us
About the Population Health Alliance
The Population Health Alliance (PHA) is a global trade association of the population health industry. The organization has nearly 100 members representing stakeholders from across the health care delivery system that seek to improve health outcomes, optimize medical and administrative spend, and drive affordability. Through its robust advocacy, research and education initiatives, the PHA offers members a forum to advance shared learning and applied research to further innovation and establish best practices in the population health field. Visit http://www.populationhealthalliance.org to learn more. Read the full story at http://www.prweb.com/releases/2014/11/prweb12346892.htm .

Population Health Alliance Welcomes New Members

Vree Health's TransitionAdvantage??? Now Available to Amerinet Members
October 01, 2014 --
ANNANDALE, N.J., Oct. 1, 2014 /PRNewswire/ -- Vree Health, a company that combines technology with direct personal patient engagement to influence positive behavioral change and help improve outcomes, has a new, choice agreement to provide care transition management services to Amerinet, a leading healthcare solutions organization. Under the agreement, Amerinet members, which include acute and non-acute care hospitals, surgery centers, long-term care facilities, clinics and doctors' offices, will receive access to TransitionAdvantage from Vree Health. The solution is a scalable, post-discharge care coordination service that integrates technology and personal interaction to help improve performance and quality scores related to 30-day readmission rates, enhance patient satisfaction and reduce potential Medicare reimbursement penalties. Amerinet selected Vree Health as an approved vendor within its Population Health Management initiative. "Vree Health and Amerinet share a common strategy focused on population health management, which includes patient flow management, patient engagement, care coordination, and population health analytics," said Kyle Dolbow, president, Vree Health. "The goal is to help healthcare organizations improve connections between providers and patients, and ultimately deliver better outcomes and enhanced patient care. "
TransitionAdvantage addresses four primary causes of preventable hospital readmissions  incomplete handoff and visibility, lack of follow-up, medication management, and lack of care coordination. Vree Health is also offering a limited number of pilot opportunities to Amerinet members, thus adding significant benefits to the contract, which runs through May 31, 2017. About Vree Health
Vree Health LLC, a subsidiary of Merck Sharp & Dohme Corp., is dedicated to helping healthcare organizations influence positive behavioral change and improve patient outcomes with technology-enabled services designed to improve the reach, cost-efficiency and efficacy of healthcare. Our innovative EngageAdvantage technology platform and high-touch services are designed to help coordinate care across providers; aggregate, analyze, and effectively utilize disparate data sources; and engage patients and their families in actively managing patient care. To learn more, visit www.vreehealth.com or www.vreehealth.com/amerinet . About Merck
Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.merck.com and connect with us on Twitter, Facebook and YouTube. About Amerinet
As a leading national healthcare solutions organization, Amerinet collaborates with acute and non-acute care providers to create and deliver unique solutions through performance improvement resources, guidance and ongoing support. With better product standardization and utilization, new financial tools beyond contracting and alliances that help lower costs, raise revenue and champion quality, Amerinet enriches healthcare delivery for its members and the communities they serve. To learn more about how Amerinet can help you successfully navigate the future of healthcare reform, visit www.amerinet-gpo.com . Forward-Looking Statement
This news release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Merck's management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Merck's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Merck's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions. Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Merck's 2013 Annual Report on Form 10-K and the company's other filings with the Securities and Exchange Commission (SEC) available at the SEC's Internet site ( www.sec.gov ). SOURCE  Vree Health
Page: 1
Related Keywords:USA, Medicine, Surgery, Insurance, healthcare, Surgery, Medication, Seniors Health, Seniors, Insurance Companies, Business, Science, Financial, Healthcare, Hospitals, Long-Term Care Facilities, Management Services, Internet Technology, Medical, Internet, Other,
Source:PR Newswire. All Rights Reserved
DMO TEXT LINKS

Vree Health Signs Choice Agreement to Provide Care Transition Management Services to Amerinet

Of the patients who receive services, a sizable majority (70 to 80 percent) express satisfaction with all the services used. Select patient services are highly valued and yet severely underserved, underutilized or nonexistent. However, those patients who receive services like them and greatly value them, according to an Accenture survey of 2,000 patients in the United States.The survey found that those who don't receive them want to—and expect pharmaceutical companies to provide them either directly or through their health care providers.Further, patients are perfectly happy receiving these services through digital channels or enabled by them, as they are spending multiple hours a day online already.For example, Vree Health, a subsidiary of Merck, launched a unique suite of services leveraging technology to help engage patients in their own care in a variety of care settings. Their services are designed to help hospitals and health systems implement innovative models of care aimed at improved quality and outcomes at a lower cost. More than three-quarters (76 percent) of patients think pharmaceutical companies have a responsibility to provide information and services that help patients manage their own health. Nearly as many respondents, 74 percent, indicated that the most appropriate time to initiate outreach is when they start making a medication, although half of the respondents are open to receiving assistance after they have begun a course of treatment or are considering switching.The report also indicated that patients are generally very satisfied with patient services when they get them—and are willing to give more personal health information to obtain more relevant services.Of the patients who receive services, a sizable majority (70 to 80 percent) express satisfaction with all the services used. In addition, patients appear to place high importance on services, providing a strong indication that services are viewed as a "should offer" not a "nice to offer" add-on—dependent on the type of medicine or treatment.Patients are also ready and willing to share information in order to receive improved or free services, the survey found.Eighty percent of patients are proactively seeking information about the medicines they are taking, and more than 70 percent seek out information on health care services related to their conditions.Nearly four in 10 (38 percent) want pharmaceutical companies to reach them through social media—a significantly higher percentage than what they want from physicians, pharmacists, friends and family. "There is a clear need for pharmaceutical companies to understand patient communication preferences and customize channels and content to provide relevant customer experiences at scale," the report said.Perhaps not surprisingly, patients place the highest trust in information provided by their physicians through print (presumably in person or at a facility) or by email.

Digital Services Are of Increasing Importance to Patients

Steve Hoepler, an executive at Merck subsidiary Vree Health, will join the board of advisers for the Mill City Innovation & Collaboration Center.

Hoepler is vice president of product development at Pennsylvania-based Vree Health, which makes technology that helps health care providers manage transitional care.

Mill City Innovation & Collaboration Center, based in Minneapolis, aims to connect health care organizations with technology companies. It’s partnered with the University of Minnesota toâ¦

Exec at Merck subsidiary joins Innovation Center advisory board

Intalere is a national healthcare solutions organization. The company collaborates with acute and non-acute care providers – hospitals, surgery centers, long-term care facilities, clinics and doctor offices – to create and deliver solutions.

On November 5, 2020 Intalere was acquired by Vizient. The terms of the transaction were not disclosed.

Intalere

Amerinet selected Vree Health LLC as an approved vendor within its Population Health Management initiative .

RTI International is a scientific research institute that conducts research across various sectors. The company provides services including data modernization, technology development, program evaluation, and innovation acceleration for government and commercial clients. RTI's expertise includes environmental protection, public health, education, justice research and policy, energy, and agriculture. It was founded in 1958 and is based in Durham, North Carolina.

RTI International

Comcast

MediSolutions

Merck

Bioclinica

The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.

Value-Based Care & Population Health

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Digital Health

Acquired

Vree Health is a provider of service-enabled care coordination technology designed to influence positive behavioral change and enhance the patient experience. The company's patient engagement and care management platform is designed to help coordinate care across providers; aggregate, analyze, and effectively utilize disparate data sources; and engage patients and their families in actively managing patient care.

Date	Round	Amount	Investors	Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.	Revenue	Sources
10/21/2015	Acquired		PatientSafe Solutions	$XXM	0 FY undefined	1
	Other Investors		Subscribe to see more	$XXM	0 FY undefined	0

Date	10/21/2015
Round	Acquired	Other Investors
Amount
Investors	PatientSafe Solutions	Subscribe to see more
Valuation	$XXM	$XXM
Revenue	0 FY undefined	0 FY undefined
Sources	1	0

First funding	Last Funding	Investor	Rounds	Board Seats	Type	Location
10/21/2015	10/21/2015	PatientSafe Solutions	1 Acquired		Corporation	California
		Merck	Subscribe to see more		Corporation	New Jersey

First funding	10/21/2015
Last Funding	10/21/2015
Investor	PatientSafe Solutions	Merck
Rounds	1 Acquired	Subscribe to see more
Board Seats
Type	Corporation	Corporation
Location	California	New Jersey

How VCs Use CB Insights

Professional Services

Platform Overview

Vree Health

Investors Count

Funding, Valuation & Revenue

Vree Health Investors